Integrating patient-centricity along the commercialization path in multiple myeloma
Change keeps changing.
The pace and scale of change in hematology and oncology is both unprecedented and unrelenting.
From multiple myeloma to DLBCL to sickle cell disease, therapeutic innovation is creating gains in survival and tolerability that would have defied belief less than a decade ago.
We are witness to a rapidly unfolding new world of people truly living their lives—with or without cancer.
These extraordinary breakthroughs—coupled with the pace at which they are arriving—bring no shortage of complexity and confusion for all involved.
Marketing in this world requires the rapid ability to navigate these waves of complexity while simultaneously creating clarity. It requires the ability to iteratively synthesize the multifaceted forces at play in oncology to provide relevance for all involved. Relevance for more people. Relevance that endures. It's this relevance that makes brands thrive.
This is what we believe. This what we are built for. This is what we do with and for hematology and oncology brands looking to thrive in a world that will not stop changing.
Let's connect.
Together we'll work wonders.
What we do
We imagine, create, and nurture biopharma brands across their entire lifecycles.
Launch brands and campaigns
We combine broad and deep expertise in launch campaigns with unconventional creativity—in biopharma, in rare disease, and in oncology—to ensure that brands thrive, make lasting impacts, and drive real results.
product launches
first-to-market launches
product launches in oncology
new MOA and/or class launches
Translate clinical data into relevant benefits
We make new therapies' innovative science meaningful and motivating.
For a novel multiple myeloma treatment, we worked to rapidly empathize with every key audience and stakeholder group.
We generated insight by examining the intersections of biomolecular science, clinical oncology, healthcare delivery systems, and patient and supporter communities.
The branded launch campaign made a therapy at the vanguard of oncology treatment relevant and personal, translating a “first and only” status into “the one with the power to help me” positioning.
Create brand relevance
We created an integrated disease-state and branded launch campaign ecosystem to deliver a coherent narrative about a significant unmet need in oncology and a novel therapy's unique ability to address it.
%
adoption of campaign and omnichannel strategy by local markets
%
positive HCP post-call recall of rep-delivered messages
%
of targeted HCP audience were aware of MOA and associated it with client company at time of launch
Create greater engagement through greater relevance
We harnessed the power of data, Al, educational content, and paid media to encourage accurate diagnosis and motivate hard-to-find patient and supporter audiences.
x
the industry benchmark for Content Engagement
x
the industry benchmark for Click Through Rate
%
of the target audience indicated they were interested in educational content that also supported the brand's objectives
What we think
We write, present, and share our thinking because we are committed to the relentless pursuit of greater relevance in biopharma marketing. Because relevance is not achieved once and then preserved forever, we study the present, anticipate the future, and always reserve the right to become smarter.
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
CAR-T: Marketing the promise, delivering beyond the need
Who we are
We are a diverse collection of multidisciplinary marketing experts who work with client teams to imagine, create, and nurture brands that thrive.
Let's work wonders together
Contact usLet's connect
Get in touch to discuss how we think, how we work, and how we can work wonders together.
Contact us